0Q6H.L - Hofseth BioCare ASA

LSE - LSE Delayed price. Currency in NOK
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 32.74%
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8178.06M
% held by insiders 158.96%
% held by institutions 120.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 3�
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin -103.81%
Operating margin (ttm)-97.90%

Management effectiveness

Return on assets (ttm)-20.85%
Return on equity (ttm)-126.49%

Income statement

Revenue (ttm)134.43M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)45.40%
Gross profit (ttm)28.51M
EBITDA -125.05M
Net income avi to common (ttm)-139.56M
Diluted EPS (ttm)-0.3780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.85M
Total cash per share (mrq)0.06
Total debt (mrq)101.03M
Total debt/equity (mrq)89.68
Current ratio (mrq)0.83
Book value per share (mrq)0.29

Cash flow statement

Operating cash flow (ttm)-36.26M
Levered free cash flow (ttm)-61.52M